Submissions for variant NM_001018005.2(TPM1):c.461T>C (p.Ile154Thr)

Total submissions: 1

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Ambry Genetics	RCV004991007	SCV005522309	likely pathogenic	Cardiovascular phenotype	2024-10-29	criteria provided, single submitter	clinical testing	The p.I154T variant (also known as c.461T>C), located in coding exon 4 of the TPM1 gene, results from a T to C substitution at nucleotide position 461. The isoleucine at codon 154 is replaced by threonine, an amino acid with similar properties. This variant was reported in individuals with features consistent with hypertrophic cardiomyopathy (HCM) (Walsh R et al. Genet Med, 2017 Feb;19:192-203; Ambry internal data). This missense alteration is located in a region that has a low rate of benign missense variation (Lek M et al. Nature. 2016 Aug 18;536(7616):285-91; DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources. Firth H.V. et al. 2009. Am.J.Hum.Genet. 84, 524-533 (DOI: dx.doi.org/10/1016/j.ajhg.2009.03.010)). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the majority of available evidence to date, this variant is likely to be pathogenic.